oseltamivir

GPTKB entity

Statements (51)
Predicate Object
gptkbp:instanceOf antiviral drug
gptkbp:approvalYear 1999
gptkbp:approvedBy gptkb:FDA
gptkbp:ATCCode J05AH02
gptkbp:brand gptkb:Tamiflu
gptkbp:CASNumber 196618-13-0
gptkbp:category antiviral
prodrug
neuraminidase inhibitor
gptkbp:chemicalFormula C16H28N2O4
gptkbp:contraindication hypersensitivity to oseltamivir
gptkbp:developer gptkb:Gilead_Sciences
gptkbp:discoveredBy gptkb:Norbert_Bischofberger
gptkbp:eliminationHalfLife 1–3 hours
gptkbp:excretion renal
gptkbp:firstSynthesized 1996
gptkbp:form capsule
oral suspension
https://www.w3.org/2000/01/rdf-schema#label oseltamivir
gptkbp:IUPACName ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
gptkbp:KEGGID D08367
gptkbp:legalStatus prescription only
gptkbp:marketedAs gptkb:Roche
gptkbp:mechanismOfAction neuraminidase inhibitor
gptkbp:metabolism hepatic
gptkbp:molecularWeight 312.4 g/mol
gptkbp:patentExpired 2016 (US)
gptkbp:pregnancyCategory C (US)
gptkbp:prodrugOf oseltamivir carboxylate
gptkbp:PubChem_CID gptkb:CHEMBL123
65028
DB00198
gptkbp:routeOfAdministration oral
gptkbp:sideEffect nausea
vomiting
headache
neuropsychiatric effects
gptkbp:storage room temperature
gptkbp:UNII R7T0KZ6CM4
gptkbp:usedFor treatment of influenza A
treatment of influenza B
gptkbp:WHOModelListOfEssentialMedicines yes
gptkbp:bfsParent gptkb:Influenza_A
gptkb:Influenza_virus
gptkb:shikimic_acid
gptkb:influenza_B_virus
gptkb:H5N1
gptkb:H7N9
gptkb:Influenza_A_virus
gptkb:Seasonal_influenza
gptkbp:bfsLayer 5